Summary
Elevance Health, Inc. has reaffirmed its 2025 earnings per diluted share guidance, projecting it to be between $30.40 and $31.10. This guidance includes approximately $3.75 per diluted share attributed to net unfavorable items. Excluding these specific items, the company anticipates adjusted earnings per diluted share to range from $34.15 to $34.85. Furthermore, Elevance Health expects its total medical enrollment for the full year 2025 to align with projections previously shared in its Fourth Quarter 2024 Earnings Release. Notably, this includes an expectation for Medicare Advantage membership to fall between 2.2 million and 2.25 million members. These reaffirmations are being communicated as company officers engage with investors over the coming weeks.
Key Highlights
- 1Reaffirms 2025 full-year shareholders' earnings guidance of $30.40 to $31.10 per diluted share.
- 2Guidance includes approximately $3.75 per diluted share for net unfavorable items.
- 3Adjusted shareholders' earnings guidance for 2025 is projected between $34.15 and $34.85 per diluted share, excluding unfavorable items.
- 42025 year-end total medical enrollment is expected to be consistent with previous guidance.
- 5Projects Medicare Advantage membership to be between 2.2 million and 2.25 million members for year-end 2025.
- 6Information is being shared during investor meetings over the next several weeks.